
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited DSO 2011-2026 | QTNT
DSO Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 45.1 | 60.4 | 41.9 | 42.2 | 42 | 44.7 | 35.8 | 45.1 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 60.4 | 35.8 | 44.7 |
DSO Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.2 | 16.9 | 29.2 | - | 50 | 15 | 21.9 | 45.1 | 47.3 | 47.2 | 29.8 | 56.3 | 53.8 | 52 | 46.9 | 31.9 | 33 | 36.6 | 41.9 | - | 34.9 | 40.6 | 35.8 | - | 52.7 | 17.2 | 17.8 | - | 37.7 | 14.7 | 20.1 | - | 52.4 | 18.5 | 24.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 56.3 | 14.7 | 35.9 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
63.8 | $ 118.41 | 0.73 % | $ 36 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 427.96 | -0.55 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.01 | -20.38 % | $ 371 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.9 | 0.51 % | $ 1.14 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.96 | -4.16 % | $ 402 M | ||
|
Natera
NTRA
|
81.5 | $ 216.86 | 4.88 % | $ 21.3 B | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.0 | 7.91 % | $ 356 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.96 | 1.26 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 473.89 | 1.54 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.6 | -0.22 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 25.04 | 1.77 % | $ 696 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 59.41 | 4.78 % | $ 3.55 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 184.56 | -0.45 % | $ 9.15 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Waters Corporation
WAT
|
306 | $ 348.79 | 1.76 % | $ 20.8 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.05 | 1.01 % | $ 455 M | ||
|
Guardant Health
GH
|
46.1 | $ 92.61 | 3.45 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 123.81 | 2.05 % | $ 10.2 B | ||
|
Illumina
ILMN
|
61.3 | $ 141.88 | 2.02 % | $ 22.6 B | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 5.38 | 7.6 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.22 | 1.6 % | $ 5.1 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 85.47 | -0.41 % | $ 5.77 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 257.38 | 0.09 % | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.16 | -1.19 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 189.95 | -0.47 % | $ 21.1 B |